We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Link between Drop in Hormone Therapy Use and Drop in Mammography Rates

By MedImaging International staff writers
Posted on 31 Aug 2011
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is associated with lower mammogram rates among these women.

Published online in August 2011 in the journal Cancer, the study’s findings suggest that when women stop seeing their physician for HT prescriptions, physicians do not have the opportunity to remind them that their mammograms are due.

Since rates were first measured in 1987, more women got a mammogram yearly than in the year before--that is, until 2005. That year saw the first-ever drop in mammography rates. What caused the change and could a sudden deduction in HT use at about that time have played a role was recently evaluated in a new study. A widely publicized report that tied HT use with breast cancer led to a drastic decline in the use of HT between 2000 and 2005. Because current users of HT also tend to have higher mammography rates, Nancy Breen, PhD, of the US National Cancer Institute (Rockville, MD, USA) and her colleagues speculated that women who stopped taking HT might also have stopped getting mammograms. The idea was that if women typically need to see a doctor to renew their HT prescription and physicians typically take that opportunity to discuss and order mammograms, then stopping the HT prescription visits would result in a lost opportunity for doctors to remind women about mammograms.

To evaluate their hypothesis, the researchers analyzed the leading national source of health data for the US population, the National Health Interview Survey, which is also the largest population-based national sample on mammography use. The study examined 7,125 women who were interviewed in 2000 and 7,387 women who were interviewed in 2005, all of whom were aged 50 years or older. The investigators found that the dramatic drop in use of HT helps explain the slight drop in mammography observed between 2000 and 2005 for women 50 to 64 years but not for women aged 65 years and older. Other factors that were associated with whether a woman got a mammogram included her education level, the type of health insurance coverage she had, and how recently she had last visited her physician.

“Our research corroborates that a doctor’s recommendation is an important step in getting a mammogram and it shows that when circumstances change--such as evidence about HT--it can upset the balance and lead to unanticipated and undesirable changes in mammography use," said Dr. Breen. “In short, we need to continue to ensure that women know about mammography and where they can get it. Mammography also needs to be affordable and convenient for women.”

Dr. Breen added that mammography is the best way to detect breast cancer early, when treatment is most effective.

Related Links:

US National Cancer Institute



Adjustable Mobile Barrier
M-458
Portable X-ray Unit
AJEX140H
Post-Processing Imaging System
DynaCAD Prostate
Half Apron
Demi

Channels

General/Advanced Imaging

view channel
Image: A multinational study reports that AI can quickly generate clinically acceptable radiotherapy plans across care settings (Photo courtesy of Adobe Stock)

AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer

Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.